U.S. third-quarter productivity beats forecasts; pay increasing
WASHINGTON (Reuters) – Productivity at U.S. nonfarm businesses increased more than expected in the third quarter, keeping a lid on wage inflation.
Strong advertising sales push AOL revenue above estimates
(Reuters) – Digital media company AOL Inc reported better-than-expected quarterly revenue as more advertisers used its real-time bidding platform to place ads on third-party websites.
Euro edges higher, stocks sag before ECB meeting
LONDON (Reuters) – The euro edged higher and European stocks pulled back on Thursday as investors waited to see how ECB chief Mario Draghi responds to another run of poor euro zone data and reports of disquiet about his leadership style.
Media giants ride streaming, cable fees past ad uncertainty
LOS ANGELES (Reuters) – Major media companies have become far less dependent on the cyclical advertising market, reporting another strong quarter of profits boosted by checks written by streaming services such as Netlfix Inc and fees from cable operato…
Tax changes weaken case for new Pfizer bid, says AstraZeneca CEO
LONDON (Reuters) – Recent U.S. tax changes have weakened the case for companies like Pfizer to shift their tax bases overseas by striking so-called tax inversion deals, according to AstraZeneca’s chief executive.
UK banks face break-up threat as competition probe launched
LONDON (Reuters) – Britain’s big banks could be broken up after the country’s competition watchdog launched a full-blown investigation into services for small business customers and personal accounts because of a lack of competition.
EU’s finance chief to unveil capital market plan in 2015
BRUSSELS (Reuters) – The EU’s new financial services chief pledged on Thursday to set out his plans for a pan-European capital market by the middle of next year, aiming to reduce companies’ reliance on banks and help revive the bloc’s fragile economy.
AstraZeneca gets sales boost as Nexium drug keeps on giving
LONDON (Reuters) – AstraZeneca raised its 2014 sales forecast for the second quarter in a row on Thursday, as the delayed arrival of generic copies of its Nexium drug in the United States kept cash flowing from the heartburn and ulcer pill.
AstraZeneca gets sales boost as Nexium drug keeps on giving
LONDON (Reuters) – AstraZeneca raised its 2014 sales forecast for the second quarter in a row on Thursday, as the delayed arrival of generic copies of its Nexium drug in the United States kept cash flowing from the heartburn and ulcer pill.
ECB to wait for stimulus to sink in, Draghi style in limelight
FRANKFURT (Reuters) – The European Central Bank is set to stick to the policy path laid out over the summer when it meets on Thursday, waiting for its stimulus to unfold before considering further steps.
